The MHCAG in 2023 and 2024
MHCAG's most productive year in 2023 through publications on medication treatment for adults with GAD, antipsychotic medication algorithms for schizophrenia, and more. Plus, discover the group's increased consultations with the P&T Committee. Look ahead to 2024 with potential topics and planned revi
2 views • 4 slides
Understanding Antipsychotic Drugs and Their Classification
Antipsychotic drugs, also known as neuroleptics, are essential in treating schizophrenia and other psychotic disorders. They work by targeting dopamine and serotonin receptors in the brain, managing symptoms like hallucinations and delusions. Learn about the dopamine-serotonin hypothesis of schizoph
9 views • 21 slides
Overview of Antipsychotic Drugs and Treatment for Psychotic Disorders
Antipsychotic drugs play a vital role in managing psychotic disorders by targeting dopamine and serotonin receptors. This overview covers the mechanism of action, classification (typical vs. atypical), side effects, and therapeutic efficacy of antipsychotic medications. It also delves into the mood-
0 views • 31 slides
Understanding Body Weight Gain in Clozapine-Treated Patients: Norclozapine's Role
Dive into the investigation by Naomi Jessurun, PharmD, exploring whether norclozapine is responsible for body weight gain in patients treated with clozapine. The research delves into the impact of drug metabolization and metabolites on adverse reactions, shedding light on the complexities surroundin
0 views • 43 slides
Facility Improvement and Program Audit in Oklahoma Healthcare
The data showcases quarterly performance percentiles and quality measures in Oklahoma healthcare facilities, highlighting changes in anti-psychotic medication, pressure ulcers, urinary tract infections, and excess weight loss. Furthermore, program audit outcomes reveal common trends such as high tur
0 views • 4 slides